NCBiotech News
We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.
September 23, 2020
NC bioscience companies getting federal SBIR/STTR R&D funding will soon have a chance to win matching funds from the state, thanks to new funding for the One NC Small Business Program.
September 22, 2020
San Diego-based Illumina, which founded GRAIL in 2016 and then spun it off as a standalone business, is now buying the unique cancer-testing company, with plans for a Durham factory, for $8 billion.
September 21, 2020
The University of North Carolina at Chapel Hill and BASF Corporation are joining forces to address global challenges.
September 21, 2020
Syngenta has donated four custom plant growth chambers valued at $1.5 million to NC State's Plant Sciences Initiative.
September 17, 2020
RTP medical device company TransEnterix is establishing the first Asia-Pacific training center for its Senhance Surgical System at the Saitama Medical University International Center in Tokyo.
September 15, 2020
Biogen announces a $250 million, 20-year initiative – Healthy Climate, Healthy Lives – to eliminate fossil fuel emissions across all its operations by 2040.
September 14, 2020
Getting accurate, timely information on COVID-19 cases is one of the major challenges facing policymakers as they make decisions about public health and the economy. Researchers at North Carolina State University are embarking on a project aimed at making sure test kits are available where they are most needed, so that policymakers have the information they need.
September 10, 2020
The innovative California-based cancer-detection company GRAIL, Inc., which is establishing a $100 million-plus facility in Research Triangle Park, is preparing to go public.
September 10, 2020
Raleigh-based AgEye Technologies, which typically provides its indoor farming customers AI-powered cameras, sensors and predictive analytics, has added its pandemic-beating “plant scientist in a box” to its portfolio.
September 9, 2020
A researcher in the Brody School of Medicine at East Carolina University is using an NCBiotech grant to study the human and environmental safety of NoPest, an ECU-created novel pesticide aimed at mosquito control.
September 8, 2020
Burlington-based LabCorp has developed the first testing method to simultaneously detect for COVID-19, influenza A / B, and respiratory syncytial virus (RSV) just in time for the upcoming flu season.
September 8, 2020
RedHill Biopharma, an Israeli company with U.S. headquarters in Raleigh, says one of its drug candidates, opaganib, completely inhibited the replication of the coronavirus that causes COVID-19 in a laboratory study.
September 4, 2020
Novartis has renamed its previously acquired AveXis gene therapy arm. It's now called Novartis Gene Therapies.
September 2, 2020
GeneCoda executive Don Alexander shares results of a 100-company survey his team conducted to understand the COVID-19 impact on life sciences businesses.
September 2, 2020
RTI International and Duke University’s Human Vaccine Institute will collaborate in a global project to identify viruses and other pathogens in wildlife that could cause disease in people, such as the coronavirus responsible for the COVID-19 pandemic